ADvantage Therapeutics

About:

ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.

Website: https://advantagetherapeutics.com/

Description:

ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease. The company is developing potentially paradigm-changing therapies to treat AD in its labs at the Vienna BioCenter.

Total Funding Amount:

$15.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Miami, Florida, United States

Founded Date:

2021-01-01

Founders:

Agustin Fernandez III

Number of Employees:

11-50

Last Funding Date:

2023-07-12

IPO Status:

Private

Industries: